homehealthcare NewsGennova Bio gets DCGI's emergency use authorisation nod for its mRNA COVID vaccine

Gennova Bio gets DCGI's emergency use authorisation nod for its mRNA COVID vaccine

Gennova is an am of Emcure Pharma Co that aims to produce around 40-50 lakhs of doses per month that can be further doubled in a short amount of time.

By CNBCTV18.com Jul 4, 2022 6:34:18 PM IST (Updated)

2 Min Read
India's first home-grown mRNA Covid-19 vaccine by Gennova Biopharma has received the EUA approval from the Drugs Controller General of India (DCGI). The vaccine-GEMCOVAC-19, which is seen as a game-changer in the Indian healthcare industry, will be given to people aged 18 years and above.
The Indian mRNA vaccine has an edge over its other international competitors like Pfizer-BioNTech and Moderna's vaccines as it does not require sub-zero temperatures for its storage.
Media reports said that the Subject Expert Committee (SEC) has recommended granting the Emergency Use Authorisation (EUA) to the Gennova Bio's vaccine.